Hemorrhagic Kaposi's sarcoma

Kaposi's sarcoma, also known as sarcoma of the genitals, is a malignant tumor that affects the skin tissue, mucous membranes and internal organs. It occurs infrequently - approximately 1% of cancer cases in men and 5% in women. However, Kaposi's sarcoma has a high mortality rate and requires immediate diagnosis and treatment. In this article we will take a closer look at Genital Kaposi's Sarcoma (GKS) and its causes, diagnostic methods and treatment of this dangerous disease.

Kaposi's sarcoma is a malignant tumor that arises from endothelial cells that make up the vascular wall and tissue lining. It is of embryonic origin, which makes it a predisposing factor for development in the body. Sarcoma is a fairly common cancer in adults over 40 years of age. Approximately 1 in 70 males over 45 years of age may experience the disease, and among older women the figure is 1 in every 94 women over 55 years of age. Most cases of SGC occur in the presence of concomitant viral infections: herpes, HIV, hepatitis. People with pre-existing immunodeficiency conditions are more likely to get the disease. It has also been observed that patients with serious blood disorders such as leukemia often experience FBS. Approximately half of the patients with this pathology do not have symptoms that allow one to suspect the pathology in time and seek specialized medical care. The main symptoms of Kaposi's sarcoma include: atrophic and necrotic skin changes; hair loss; ulcerative lesions of the mucous membranes; lymphadenopathy; fever and weight loss. There is no specific method for diagnosing SGC